Conatus Pharma Stock Price (NASDAQ:CNAT)

Add to My Stocks
$4.97 $0.02 (0.4%) CNAT stock closing price Jun 22, 2018 (Closing)
Prev Close* : $4.99
Market Cap:
$149.41M
Day Low: $4.88
52 Week Low: $3.22
Open: $5.01
Volume: -
Day High: $5.07
52 Week High: $7.95
Dividend:
0.00

Latest Stock Market News

Latest Articles

Conatus Pharma News - From Partners

CNAT Stockcharts

View CNAT PE ratio, PS ratio stocks charts and compare with peers.
CNAT Chart
Note: Compare Conatus Pharma stock price history with the index and industry peers.

Conatus Pharma Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
3.92
PB ratio (
price to book ratio
)
5.48

Conatus Pharma Returns

ROE
(return on equity)
-69%

Conatus Pharma Financial Ratios

Asset Turnover
0.49
Receivables Turnover
11.77
Debt to Equity
0.57
Dividend Yield
0%

CNAT Industry Peers

Company Price Change (%)
Fonar (FONR)27.550.35 (1.29%)
Biolife Solutions (BLFS)12.611.09 (9.46%)
Intercept Pharma (ICPT)85.671.56 (1.85%)
Medicinova (MNOV)8.610.05 (0.58%)
Galmed Pharma (GLMD)14.090.3 (2.08%)
Tracon Pharma (TCON)2.850.1 (3.64%)
Viking Therapeutics (VKTX)11.080.44 (4.14%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
BioLife Solutions (BLFS)12.611.09 (9.46%)
Owens & Minor (OMI)17.80.91 (5.39%)
VERU INC (VERU)2.250.06 (2.74%)
Chembio Diagnostics (CEMI)10.650.25 (2.4%)
NanoString Technologies (NSTG)14.50.21 (1.47%)
Boston Scientific (BSX)32.620.47 (1.46%)
MacroGenics (MGNX)22.990.31 (1.37%)
Top gainers from Medical Products industry
* As of Jun 23, 2018
CompanyPriceChange (%)
Insys Therapeutics (INSY)8.150.26 (3.09%)
NuVasive (NUVA)53.811.69 (3.05%)
Cerus (CERS)7.030.15 (2.09%)
ICU Medical (ICUI)294.655.05 (1.69%)
Rockwell Medical (RMTI)5.30.09 (1.67%)
Chimerix (CMRX)4.760.08 (1.65%)
Phibro Animal Health (PAHC)47.350.6 (1.25%)
Top losers from Medical Products industry
* As of Jun 23, 2018

Conatus Pharmaceuticals Inc Stock News - Partner Headlines

Conatus Pharma Financial Statements

income statement20172016201520142013
Net Sales or Revenues35.37M----
Net Income-17.39M-29.73M-24.14M-22.31M-15.61M
Total Operating Expense52.92M30.62M24.12M22.27M11.59M
View Conatus Pharma income statement
balance sheet20172016201520142013
Total Assets81.94M82.32M39.72M38.44M56.93M
Total Liabilities53.94M60.53M5.18M5.23M3.81M
Shareholders Equity27.99M21.78M34.54M33.21M53.11M
View Conatus Pharma balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-20.6M53.26M-2.1M1.11M-
Net Cash from (used by) Operating Activities-33.21M26.99M-22.54M-18.26M-10.63M
Increase (Decrease) in Prop Plant And Equipment-0.02M-0.1M-0.08M-0.24M-
View Conatus Pharma cash flow statement

Conatus Pharma Stock Message Board

An investor needs to spend $4.97 to buy CNAT stock, as the closing Conatus Pharma stock price is $4.97. Stock price or share price can be used to find the total market value of a company. Conatus Pharma market cap stands at $149.41M as of Jun 22, 2018. Conatus Pharma valuation can be guaged using various valuation metrics like the price to earnings ratio.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Conatus Pharma is worth a lot, it will most likely be reflected in an inflated Conatus Pharma stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. The volume of shares traded stood at 3,171,154 on the last trading day, as is evident from Conatus Pharma stock chart, and CNAT stock quote data. Conatus Pharma paid 0.00 stock dividends to its shareholders during last quarter. One can observe stock price trends and check for volatility by checking Conatus Pharma stock price history.